Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers.
(b) On May 1, 2023 (the "Termination Date"), in connection with the planned
closure of the Company's San Diego, CA office, Armata Pharmaceuticals, Inc. (the
"Company") terminated the employment of Erin Butler, Vice President, Finance and
Administration (and principal financial officer and principal accounting
officer) of the Company, effective as of close of business on the Termination
Date.
(c) On May 4, 2023, the Company's Board of Directors (the "Board") appointed
Julianne Averill to serve, effective as of May 2, 2023, as Chief Financial
Officer of the Company and in such capacity, also serve as principal financial
officer and principal accounting officer of the Company.
Ms. Averill, age 38, has served as a senior director of Danforth Advisors, LLC
("Danforth") since August 2021. Ms. Averill has over 20 years of finance &
corporate development leadership experience, providing CFO advisory services and
supporting life science organizations with capital raise initiatives, investor
relations, and corporate strategy. Prior to Danforth, Ms. Averill held several
CFO and other operational executive roles of increasing responsibility at
leading public and private companies operating at the intersection of technology
and science, including serving as CFO for Alveo Technologies from July 2020 to
August 2021; VP Finance & Executive Committee Member for BlackThorn Therapeutics
from January 2019 to July 2020; Associate VP, Finance & Accounting, for Manifest
MedEx from May 2015 to January 2019, and Director of Financial Reporting for
Starwood Waypoint Residential Trust from July 2014 to May 2015. Ms. Averill
spent her early career at Deloitte as an audit manager in its life sciences and
retail practice.
Ms. Averill is licensed as an active Certified Public Accountant in the State of
California and is a Society of Human Resource Management Certified Professional.
She holds a BS in Business Administration and an MS in Accountancy, both from
California State University, Fresno, and has received a certificate in Business
and Data Analytics from Harvard University.
Ms. Averill provides consulting services to the Company pursuant to a consulting
agreement between the Company and Danforth and receives no compensation directly
from the Company. The Company will pay Danforth an agreed upon hourly rate of
$395 for Ms. Averill's services, which is subject to monthly review and annual
increase, and will reimburse Danforth for reasonable, out-of-pocket business
expenses. The consulting agreement may be terminated by the Company or Danforth
with cause, upon 30 days' written notice, and without cause upon 60 days'
written notice.
There are no family relationships between Ms. Averill and any of the Company's
directors or executive officers. There are no related person transactions in
which Ms. Averill has a direct or indirect material interest that would be
required to be disclosed under Item 404(a) of Regulation S-K.
- 2 -
© Edgar Online, source Glimpses